Top broker Says Beaten-up ASX All Ords Stock Has 253% Upside

ASX All Ords healthcare stock Immutep Ltd (ASX: IMM) is down by 26% over the past two days, and one market analyst reckons it’s a golden buy-the-dip opportunity staring us right in the face. Immutep shares are currently trading for 32 cents, down 5.97% on Friday. The stock plummeted 47% to an intraday 52-week low of 23 cents yesterday after the…

Details

At the Money: Lose the Noise

A constant stream of noise distracts investors: earnings reports, news releases, upgrades, downgrades, economic data, geopolitics. How should we best manage this firehose of distractions? Larry Swedrow, head of financial and economic research at Buckingham Strategic Wealth, speaks with Barry Ritholtz about managing through the noise.

Stillness and The Art of Trading

Following a few recent conversations with both new traders who don’t yet know the correct path and older traders who have strayed I thought this was worth a repop. One of the most persistent things in traders is the desire to be doing something. There is a perennial confusion between effective activity and activity for…

Details